Nushen Pharmaceuticals Private Limited
About Nushen Pharmaceuticals Private Limited
Data last updated:
Nushen Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 27 March 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U36996MH2019PTC323108. Its GSTIN is 08AAGCN4668Q1ZK (Rajasthan).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹30,000. It is led by directors including Sonu Kumari and Karishama Khatri.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot 18/22 1st Floor Abbas Building D. N. Singh Road Hathi Baug, Mumbai, Maharashtra, India – 400010.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.05 Cr, a growth of 23% compared to the previous year. For the same year it recorded a net profit of ₹2.48 Lakh (net margin 2.4%) and EBITDA of ₹4.09 Lakh (EBITDA margin 3.9%). Revenue has grown at a compounded annual rate (CAGR) of 20% over three years and 48% over five years.
Company details
Contact details
Nushen Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressPlot 18/22 1st Floor Abbas Building D. N. Singh Road Hathi Baug, Mumbai, Maharashtra, India – 400010
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Nushen Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Nushen Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Nushen Pharmaceuticals Private Limited, buy the company report.
Financials of Nushen Pharmaceuticals Private Limited
FY 2025 filings availableNushen Pharmaceuticals Private Limited reported revenue of ₹1.05 Cr (up 23% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 48% over five years, including 23% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.09 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.48 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.9% | ||||
| Net Profit Margin | 2.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Nushen Pharmaceuticals Private Limited, buy the company report.
Board of directors of Nushen Pharmaceuticals Private Limited
Nushen Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sonu Kumari Also directs: Nushen Healthcare Private Limited | Director | 27 Mar 2019 | 7 Years 7 Months | Current |
| Karishama Khatri Also directs: Nushen Healthcare Private Limited | Director | 27 Mar 2019 | 7 Years 7 Months | Current |
| Adarsh Dwivedi | Additional Director | 22 Mar 2025 | 1 Years 7 Months | Current |
Peer comparison
Nushen Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Zafodo Pharmaceuticals Private Limited | ₹1.05 Cr (FY 2025) | 28.0% | Palakkad, Kerala, India | |||
| Solvmed Pharmaceuticals Private Limited | ₹1.05 Cr (FY 2025) | 6.0% | Darbhanga, Bihar, India | |||
| Nushen Pharmaceuticals Private Limitedthis company | ₹1.05 Cr (FY 2025) | ₹2.48 Lakh | 2.4% | 23.0% | Mumbai, Maharashtra, India | |
| Reddy Pharmaceuticals Limited | ₹1.05 Cr (FY 2024) | -19.0% | Hyderabad, Telangana, India | |||
| Numac Healthcare Private Limited | ₹1.05 Cr (FY 2024) | 20.0% | Gwalior, Madhya Pradesh, India |
To see the full peer comparison of Nushen Pharmaceuticals Private Limited, buy the company report.
Auditor
Nushen Pharmaceuticals Private Limited is audited by R B JAIN & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R B JAIN & ASSOCIATES | FY 2021 | 103951W |
Shareholding
The shareholding of Nushen Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Nushen Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Nushen Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nushen Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Nushen Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAGCN4668Q1ZK | Rajasthan | Active | 19 Jun 2019 |
To see the full GST registrations and return filing status of Nushen Pharmaceuticals Private Limited, buy the company report.
Recent activity
Nushen Pharmaceuticals Private Limited has 3 board changes on record since 2019: 3 appointments. The latest: Adarsh Dwivedi was appointed as Additional Director on 22 Mar 2025.
Frequently asked questions
Nushen Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 27 March 2019 (7+ years old) and is registered under CIN U36996MH2019PTC323108.
Nushen Pharmaceuticals has 3 current directors:
- Sonu Kumari - Director
- Karishama Khatri - Director
- Adarsh Dwivedi - Additional Director
The latest financial statements of Nushen Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Nushen Pharmaceuticals is 08AAGCN4668Q1ZK, registered in Rajasthan.
The CIN (Corporate Identification Number) of Nushen Pharmaceuticals is U36996MH2019PTC323108. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nushen Pharmaceuticals was incorporated on 27 March 2019, making it 7+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Nushen Pharmaceuticals by revenue are Zafodo Pharmaceuticals Private Limited, Solvmed Pharmaceuticals Private Limited, Reddy Pharmaceuticals Limited, Numac Healthcare Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading).
Adarsh Dwivedi was appointed as Additional Director on 22 Mar 2025. Karishama Khatri was appointed as Director on 27 Mar 2019. Sonu Kumari was appointed as Director on 27 Mar 2019.
The registered office of Nushen Pharmaceuticals is at Plot 1822 1st Floor Abbas Building D. N. Singh Road Hathi Baug, Mumbai, Maharashtra, India – 400010.
Nushen Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Nushen Pharmaceuticals can be reached at its registered office: Plot 1822 1st Floor Abbas Building D. N. Singh Road Hathi Baug, Mumbai, Maharashtra, India – 400010.